Publication | Open Access
The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia
10
Citations
12
References
2022
Year
DAAs regimens are associated with high rates of SVR12 and are well tolerated with a good safety profile in Saudi HCV-infected patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1